WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 16 fonti

Alibaba paga 600 milioni negli Usa: cosa c’è dietro all’accordo - SoldiOnline.it

Alibaba e Aus Merchant Services pagano 600 milioni di dollari per chiudere l’indagine USA su vendite illegali e attrezzature per farmaci contraffatti.

Raccontata daapnews.comchannelnewsasia.comcryptobriefing.comthenextweb.comabcnews.comarabnews.commorningstar.comvalor.globo.comscmp.comcaixinglobal.comthehindubusinessline.comansa.it+4 altre

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
soldionline.itStai leggendo14 h fa

Alibaba paga 600 milioni negli Usa: cosa c’è dietro all’accordo - SoldiOnline.it

Alibaba e Aus Merchant Services pagano 600 milioni di dollari per chiudere l’indagine USA su vendite illegali e attrezzature per farmaci contraffatti.

originale

Timeline cronologica

  1. mercoledì 1 luglio 2026·apnews.com

    Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales

    Alibaba has agreed to pay $600 million to settle a dispute with the U.S. government. The company faced allegations of selling and importing illegal pharmaceuticals and equipment…

  2. mercoledì 1 luglio 2026·channelnewsasia.com

    Alibaba, AUS Merchant Services to pay $600 million to resolve alleged illegal pharmaceuticals sales, DOJ says

    WASHINGTON, July 1 : The U.S. Justice Department said on Wednesday that Alibaba and AUS Merchant Services have agreed to pay $600 million to resolve allegations that they failed…

ansa.it
16 h fa

Alibaba patteggia con gli Usa, 600 milioni per chiudere indagine su vendite illegali - Notizie - Ansa.it

Alibaba e il suo processore di pagamenti statunitense Aus Merchant Services pagheranno complessivamente 600 milioni di dollari per chiudere un'indagine del Dipartimento di Giustizia degli Stati Uniti relativa alla…

Leggi questa versione → originale
cryptobriefing.com23 h fa

Alibaba to pay $600M to resolve US drug sales probe

Alibaba will pay $600 million to settle a DOJ investigation into illegal pharmaceutical sales on Alibaba.com and AliExpress.com spanning 2016 to 2024.

Leggi questa versione → originale
thenextweb.com1 g fa

Alibaba and its US payment processor will pay 600 million dollars to settle a DOJ probe into illegal drug…

Alibaba admitted its platform failed to prevent 80,000 illegal pharmaceutical purchases worth over 200 million dollars between 2016 and 2024.

Leggi questa versione → originale
channelnewsasia.com1 g fa

Alibaba, AUS Merchant Services to pay $600 million to resolve alleged illegal pharmaceuticals sales, DOJ says

WASHINGTON, July 1 : The U.S. Justice Department said on Wednesday that Alibaba and AUS Merchant Services have agreed to pay $600 million to resolve allegations that they failed to prevent illegal sales of…

Leggi questa versione → originale
benzinga.com9 h fa

Alibaba Agrees to $600 Million DOJ Deal Over Alleged Illegal Drug Sales on its Marketplaces As US Scrutin

Alibaba agrees to pay $600 million to settle DOJ allegations over illegal product sales into the U.S.

Leggi questa versione → originale
  • mercoledì 1 luglio 2026·channelnewsasia.com

    Alibaba to pay $600 million to resolve US drug sales probe

    WASHINGTON, July 1 : Chinese ‌technology and e-commerce giant Alibaba and its U.S.-based payment processor have agreed to pay $600 million to resolve allegations that they failed…

  • mercoledì 1 luglio 2026·cryptobriefing.com

    Alibaba agrees to pay $600M to settle federal probe into drug sales

    Alibaba and its US payment processor will pay $600 million to settle a federal investigation into illegal drug sales facilitated on the company's platforms.

  • mercoledì 1 luglio 2026·thenextweb.com

    Alibaba and its US payment processor will pay 600 million dollars to settle a DOJ probe into illegal drug sales

    Alibaba admitted its platform failed to prevent 80,000 illegal pharmaceutical purchases worth over 200 million dollars between 2016 and 2024.

  • mercoledì 1 luglio 2026·abcnews.com

    Alibaba to pay US $600M to settle allegations it allowed illegal sales

    Alibaba has agreed to pay $600 million to settle a dispute with the U.S. government

  • mercoledì 1 luglio 2026·arabnews.com

    Alibaba to pay US $600m to settle allegations it allowed illegal drug and equipment sales

    WASHINGTON: The Chinese tech giant Alibaba will pay $600 million to resolve a dispute with the US government over allegations that the Hangzhou-based firm sold and imported…

  • mercoledì 1 luglio 2026·morningstar.com

    Correction to Alibaba, U.S. Payment Processor in DOJ Settlement Article

    AUS Merchant Services is a subsidiary of Ant Group. "Alibaba, U.S. Payment Processor to Pay $600M in DOJ Settlement Over Illegal Drug Sales," at 3:42 p.m. ET, incorrectly said AUS…

  • giovedì 2 luglio 2026·valor.globo.com

    Alibaba chega a acordo para encerrar processo nos EUA sobre comércio de itens proibidos

    Segundo a Justiça americana, a Alibaba admitiu que falhou, entre 2016 e 2024, em impedir cerca de 80 mil vendas de produtos químicos, drogas e equipamentos de falsificação…

  • giovedì 2 luglio 2026·cryptobriefing.com

    Alibaba to pay $600M to resolve US drug sales probe

    Alibaba will pay $600 million to settle a DOJ investigation into illegal pharmaceutical sales on Alibaba.com and AliExpress.com spanning 2016 to 2024.

  • giovedì 2 luglio 2026·scmp.com

    Alibaba to pay US$600 million to settle US probe into illegal product sales

    Amount resolves dispute with US government over allegations firm sold and imported illegal pharmaceuticals and controlled substances into US.

  • giovedì 2 luglio 2026·caixinglobal.com

    Alibaba Agrees to Settle With U.S. Over Illegal Online Drug Sales

    Before accepting the $600 million settlement, the Justice Department had accused the Chinese e-commerce giant and its U.S. payment processor of failing to prevent its platforms…

  • giovedì 2 luglio 2026·thehindubusinessline.com

    Alibaba, its payment processor to pay $600 million to resolve US drug sales probe

    The companies ‌entered into non-prosecution agreements to resolve allegations that they violated the US Federal Food, Drug, and Cosmetic Act ‌by failing to prevent merchants from…

  • giovedì 2 luglio 2026·ansa.it

    Alibaba patteggia con gli Usa, 600 milioni per chiudere indagine su vendite illegali - Notizie - Ansa.it

    Alibaba e il suo processore di pagamenti statunitense Aus Merchant Services pagheranno complessivamente 600 milioni di dollari per chiudere un'indagine del Dipartimento di…

  • giovedì 2 luglio 2026·soldionline.it

    Alibaba paga 600 milioni negli Usa: cosa c’è dietro all’accordo - SoldiOnline.it

    Alibaba e Aus Merchant Services pagano 600 milioni di dollari per chiudere l’indagine USA su vendite illegali e attrezzature per farmaci contraffatti.

  • giovedì 2 luglio 2026·aljazeera.com

    Alibaba to pay $600m to settle illegal drug sales allegations in US probe

    E-commerce giant admitted it failed to ⁠prevent 80,000 illegal drug product sales, according to US Justice Department.

  • giovedì 2 luglio 2026·benzinga.com

    Alibaba Agrees to $600 Million DOJ Deal Over Alleged Illegal Drug Sales on its Marketplaces As US Scrutin

    Alibaba agrees to pay $600 million to settle DOJ allegations over illegal product sales into the U.S.

  • giovedì 2 luglio 2026·upi.com

    Alibaba to pay $600 million to U.S. for illegal pharmaceutical sales - UPI.com

    Alibaba Group will pay $600 million for allowing merchants to sell illegal pharmaceuticals, controlled substances and more in the United States.